It was discovered that the intraperitoneal administration of a 225Ac-labeled internalized anti-HER-2/neu antibody significantly extended survival in a nude mouse model of human ovarian cancer at levels that cause no obvious gross toxicity [36]. Here, ERBB2 is linked to ovarian cancer.